What are Vaccine drugs?

Vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Streptococcus pneumoniae). 122 are currently marketed, with 78 more in clinical development.

What are the marketed Vaccine drugs?

Marketed Vaccine drugs include Prevnar family, Comirnaty, Shingrix, Abrysvo, vaccinate with DTaP, Typhoid Vaccine.

Vaccine

122 marketed 78 in Phase 3

This page covers all Vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Streptococcus pneumoniae, SARS-CoV-2 virus, Varicella zoster virus.

Targets

Streptococcus pneumoniae · SARS-CoV-2 virus · Varicella zoster virus · RSV · Hepatitis B surface antigen (HBsAg) · Japanese encephalitis virus envelope proteins · poliovirus types 1, 2, and 3 antigens · Poliovirus types 1 and 3 · Hepatitis B surface antigen (HBsAg); Hepatitis A virus antigen · Neisseria meningitidis serogroup B surface antigens (recombinant proteins)

Marketed (122)

Prevnar family · Pfizer Inc. · Immunology · 6494
Induces an immune response to Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F
Comirnaty · Pfizer Inc. · Infectious Disease · 5400
Comirnaty is an mRNA-based vaccine.
Shingrix · GSK · Immunology · 4300
Abrysvo · Pfizer · Infectious Disease · 1033
ABRYSVO is a vaccine that protects against respiratory syncytial virus (RSV).
vaccinate with DTaP · Zhejiang Provincial Center for Disease Control and Prevention · Immunology
DTaP vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria toxin, tetanus toxin, and pertussis antigens.
Typhoid Vaccine · University of Oxford · Infectious Disease
The typhoid vaccine stimulates the immune system to produce antibodies and cellular immunity against Salmonella typhi, the bacterium that causes typhoid fever.
Hepa-B · International Centre for Diarrhoeal Disease Research, Bangladesh · Immunology / Infectious Disease
Hepa-B is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.
Bivalent Vaccines · Instituto Nacional de Salud Publica, Mexico · Immunology
Bivalent vaccines stimulate immune responses against two distinct pathogenic targets or variants simultaneously.
JE vaccine new plant lot 1 · International Centre for Diarrhoeal Disease Research, Bangladesh · Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.
Egg based influenza vaccines · Henry M. Jackson Foundation for the Advancement of Military Medicine · Immunology
Egg-based influenza vaccines stimulate the immune system to produce antibodies and cellular immunity against influenza virus strains grown in embryonated chicken eggs.
IPV at 14 and 22 weeks of age, Rotarix · Centers for Disease Control and Prevention · Immunology
IPV (inactivated poliovirus vaccine) and Rotarix (rotavirus vaccine) stimulate the immune system to produce antibodies and cellular immunity against poliovirus and rotavirus, respectively, preventing infection and disease.
fIPV (0.1 mL) ID · Centers for Disease Control and Prevention · Immunology
fIPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3.
engineered HB vaccine · Southeast University, China · Immunology / Infectious Disease
An engineered hepatitis B vaccine that stimulates immune responses to prevent hepatitis B virus infection through enhanced antigen presentation.
A second dose with an 1 year interval · Shanghai Municipal Center for Disease Control and Prevention · Immunology
A booster vaccination dose administered one year after initial immunization to maintain or enhance immune protection.
IIV4 and PPV23 · China National Biotec Group Company Limited · Immunology
IIV4 and PPV23 are inactivated influenza and pneumococcal vaccines that stimulate the immune system to produce antibodies against influenza virus strains and Streptococcus pneumoniae serotypes.
IPV at 14 and fIPV at 22 weeks, RotaTeq · Centers for Disease Control and Prevention · Immunology
IPV (inactivated poliovirus vaccine) and RotaTeq (rotavirus vaccine) stimulate the immune system to produce antibodies and cellular immunity against poliovirus and rotavirus, respectively, preventing infection and disease.
bOPV (three dose) · Centers for Disease Control and Prevention · Immunology / Infectious Disease
bOPV (bivalent oral polio vaccine) stimulates the immune system to produce antibodies against poliovirus types 1 and 3, providing protection against poliomyelitis.
Engerix-B and Twinrix · St. Joseph's Health Care London · Immunology / Infectious Disease
These vaccines stimulate the immune system to produce antibodies against hepatitis A and/or B viruses, providing protective immunity.
Rabies vaccine, manufactured by ChengDa · Peking University People's Hospital · Infectious Disease / Immunology
The rabies vaccine stimulates the immune system to produce antibodies and cellular immunity against the rabies virus, preventing infection after exposure.
Hepatitis B adjuvanted vaccine · GlaxoSmithKline · Immunology
This vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus by presenting hepatitis B surface antigen with an adjuvant that enhances the immune response.
Sabin IPV+ bOPV+ bOPV · Zhejiang Provincial Center for Disease Control and Prevention · Immunology / Infectious Disease
This is a combination polio vaccine containing inactivated poliovirus (IPV) and bivalent oral poliovirus vaccine (bOPV) that stimulates immune responses against poliovirus types to prevent poliomyelitis.
Sabin IPV + Sabin IPV + bOPV · Zhejiang Provincial Center for Disease Control and Prevention · Immunology / Infectious Disease
This is a combination polio vaccine containing inactivated poliovirus vaccine (IPV) derived from Sabin strains plus bivalent oral polio vaccine (bOPV) to provide immunization against poliovirus types 1, 2, and 3.
Aleph influenza vaccine · Beijing Center for Disease Control and Prevention · Immunology
Aleph influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains.
JE vaccine new plant lot 2 · International Centre for Diarrhoeal Disease Research, Bangladesh · Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.
Tdap Vaccine Administration · Institute of Arthritis Research · Immunology
Tdap vaccine stimulates the immune system to produce antibodies and cellular immunity against tetanus toxoid, diphtheria toxoid, and acellular pertussis antigens.
Evaluation of vaccines against flu · Assistance Publique - Hôpitaux de Paris · Immunology
Flu vaccines stimulate the immune system to produce antibodies and cellular immunity against influenza virus strains, providing protection against infection and severe disease.
Traditional HBV Vaccine · NYU Langone Health · Immunology
The traditional HBV vaccine stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.
vaccinated with bOPV · Zhejiang Provincial Center for Disease Control and Prevention · Immunology
bOPV (bivalent oral polio vaccine) stimulates the immune system to produce antibodies against poliovirus types 1 and 3, providing protection against poliomyelitis.
Meningococcal B · Canadian Immunization Research Network · Immunology
Meningococcal B vaccine stimulates the immune system to produce antibodies against serogroup B Neisseria meningitidis, preventing meningococcal disease.
Flu Vaccine (Year 3) · The Jackson Laboratory · Immunology
The flu vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in that year's formulation.
mIRV · Pfizer · Immunology / Infectious Disease
mIRV is a multivalent respiratory syncytial virus (RSV) vaccine that stimulates immune responses against RSV to prevent infection and disease.
C. difficile vaccine formulation 1. · Pfizer Inc.
Respiratory Syncytial Virus Prefusion F Subunit Vaccine · Pfizer · Cardiovascular
Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1) · Pfizer · Immunology
Tozinameran 5 to 11 Years of age · Pfizer · Immunology
RSVpreF Vaccine · Pfizer Inc. · Immunology
Combination (Bivalent) BNT162b2 and BNT162b2 OMI · Pfizer · Immunology
Hospital-Based Vaccination Pathway · Pfizer · Immunology
BNT162b2 · Pfizer · Immunology
adjuvanted trivalent influenza vaccine · Insight Therapeutics, LLC · Immunology
An adjuvanted trivalent influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against three strains of influenza virus.

Phase 3 pipeline (78)

DTaP Vaccine A · Jiangsu Province Centers for Disease Control and Prevention · Immunology
DTaP vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria toxin, tetanus toxin, and pertussis antigens.
Recombinant Herpes Zoster Vaccine · Beijing Luzhu Biotechnology Co., Ltd. · Immunology
The recombinant Herpes Zoster Vaccine works by stimulating the body's immune system to produce a specific response against the Herpes Zoster virus.
Sinovac PCV13 · Sinovac Research and Development Co., Ltd. · Immunology
Sinovac PCV13 is a vaccine that stimulates the body's immune response to protect against 13 serotypes of pneumococcal disease.
DTcP · CanSino Biologics Inc. · Immunology
DTcP is a recombinant protein subunit vaccine that stimulates immune responses against diphtheria, tetanus, and pertussis antigens.
Tritanrix-HepB/Hib™ vaccine · Sanofi Pasteur, a Sanofi Company · Immunology
Tritanrix-HepB/Hib™ vaccine works by stimulating the body's immune system to produce antibodies against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b.
Adjuvant, non-live RSV vaccine · University Health Network, Toronto · Immunology / Infectious Disease
An adjuvanted non-live RSV vaccine stimulates the immune system to produce antibodies and cellular immunity against respiratory syncytial virus without containing live virus.
Recombinant Hepatitis B Virus Vaccine · Universidad de Valparaiso · Immunology
This vaccine stimulates an immune response against the hepatitis B virus.
V920 Consistency Lot B · Merck Sharp & Dohme LLC · Infectious Disease
V920 is a vaccine designed to protect against COVID-19 by inducing an immune response against the SARS-CoV-2 virus.
Influenza vaccine GSK2321138A · GlaxoSmithKline · Immunology
GSK2321138A is a recombinant influenza vaccine designed to stimulate immune responses against influenza virus antigens.
SARS-CoV-2 rS/Matrix M1-Adjuvant · Novavax · Infectious Disease
SARS-CoV-2 rS/Matrix M1-Adjuvant is a vaccine that uses the SARS-CoV-2 spike protein and Matrix M1 adjuvant to stimulate an immune response against SARS-CoV-2.
V232 Current Process Hepatitis B Vaccine · Merck Sharp & Dohme LLC · Immunology
V232 Current Process Hepatitis B Vaccine stimulates the body's immune system to produce antibodies against the hepatitis B virus.
V110, pneumococcal vaccine polyvalent · Merck Sharp & Dohme LLC · Immunology
V110, pneumococcal vaccine polyvalent, stimulates the body's immune system to produce antibodies against pneumococcal bacteria.
SP IPT · Institute of Tropical Medicine, Belgium · Infectious Disease
SP IPT is a vaccine that targets the SARS-CoV-2 spike protein.
MenBvac · University Hospital, Rouen · Immunology / Infectious Disease
MenBvac is a meningococcal B vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup B.
VLA1553 · Valneva Austria GmbH · Infectious Disease
VLA1553 is a COVID-19 vaccine.
Td-Impfstoff Merieux · IBSS Biomed S.A. · Infectious Diseases
Td-Impfstoff Merieux is a vaccine that stimulates the body's immune response to diphtheria and tetanus.
Tritanrix™-HepB/Hiberix™ Kft. · GlaxoSmithKline · Infectious Diseases
Tritanrix-HepB/Hiberix Kft. is a vaccine that protects against diphtheria, tetanus, pertussis, hepatitis B, and Hib infections.
V503 · Merck Sharp & Dohme LLC · Infectious Diseases
V503 is a vaccine designed to prevent human papillomavirus (HPV) infection.
DTaP-IPV and ActHIB® · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
This combination vaccine stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.
Vi-DT (Multi-dose formulation) · International Vaccine Institute · Infectious Diseases
Vi-DT is a vaccine that stimulates the immune system to produce antibodies against a specific target.
Sci-B-Vac-Lot B · VBI Vaccines Inc. · Infectious Disease
Sci-B-Vac-Lot B is a vaccine that stimulates an immune response against the hepatitis B virus.
Hepatitis B vaccination · Tel-Aviv Sourasky Medical Center · Immunology
Hepatitis B vaccination stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen, preventing infection and disease.
ROTAVAC 5C -F2 · Bharat Biotech International Limited · Infectious Diseases
ROTAVAC 5C -F2 is a vaccine that protects against rotavirus infection.
V920 Consistency Lot C · Merck Sharp & Dohme LLC · Infectious Disease
V920 is a vaccine designed to protect against COVID-19 by inducing an immune response against the SARS-CoV-2 virus.
Pneumovax II · University of Oxford · Immunology
Pneumovax II stimulates the immune system to produce antibodies against Streptococcus pneumoniae.
Positive control vaccine 1 · Jiangsu Province Centers for Disease Control and Prevention · Immunology
A positive control vaccine designed to elicit immune responses by presenting antigenic material to stimulate adaptive immunity.
pneumococcal 23v polysaccharide vaccine · Merck Sharp & Dohme LLC · Immunology
This vaccine stimulates the body's immune response to produce antibodies against pneumococcal serotypes.
Pneumoccocal Vaccine · Sanofi Pasteur, a Sanofi Company · Immunology
Pneumococcal vaccine stimulates the immune system to produce antibodies against Streptococcus pneumoniae bacteria, preventing infection and disease.
Positive control vaccine 2 · Jiangsu Province Centers for Disease Control and Prevention · Immunology
A positive control vaccine designed to elicit immune responses as a reference standard in clinical trials.
Comparator: Influenza Vaccine · Merck Sharp & Dohme LLC · Immunology
Influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains, providing protection against infection.
GC3110A(Quadrivalent) · Green Cross Corporation · Immunology
GC3110A is a quadrivalent vaccine designed to stimulate immune responses against multiple disease targets.
Hib Vaccine Group · Beijing Minhai Biotechnology Co., Ltd · Immunology
Hib vaccine stimulates the immune system to produce antibodies against Haemophilus influenzae type b (Hib) bacteria, preventing infection.
DTaP-IPV-HB-Hib · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease Prevention
This combination vaccine stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b.
DTaP-IPV-HB-PRP~T · Sanofi Pasteur, a Sanofi Company · Immunology
This combination vaccine stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b.
nDC vaccination · Radboud University Medical Center · Infectious Disease
The nDC vaccination induces an immune response against the SARS-CoV-2 virus.
Vaccine for intramuscular injection · Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products · Infectious Diseases
This vaccine stimulates the body's immune system to produce a specific response against the target pathogen.
Infanrix®-IPV+Hib and Prevenar® · Sanofi Pasteur, a Sanofi Company · Immunology
This is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b, and pneumococcal disease.
Infanrix/Hib™ vaccine · GlaxoSmithKline · Immunology
Infanrix/Hib is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b (Hib) bacteria.
YF-17D · Takeda · Infectious Diseases
YF-17D is a live attenuated vaccine.
control pneumococcal polysaccharide vaccine · Aimei Vacin BioPharm (Zhejiang) Co., Ltd. · Immunology
This vaccine works by stimulating the body's immune system to produce antibodies against pneumococcal bacteria.